Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Multiple Myeloma 1 Glioma 1

Interventions

Magnetic Resonance Spectroscopy 19 Temozolomide 16 Radiotherapy 10 Specimen Handling 7 Blood Specimen Collection 7 Radiation 6 Bevacizumab 5 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 vorasidenib 3 trametinib 3 pembrolizumab 3 olaparib 3 fludarabine 3 dabrafenib 3 Watchful Waiting 3 Surgical Procedures, Operative 3 Magnetic Resonance Imaging 3 Drug Therapy 3 olutasidenib 2 lutetium Lu 177 dotatate 2 fluorodopa F 18 2 fluciclovine F-18 2 entrectinib 2 contrast agent BR1 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Flucytosine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × Quercetin × Clear all

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡